(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

DIAG-NOSE

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

DIAG-NOSE

ST13

US500000079325427

Classe

5, 9, 10

Pedido

79325427

Registro

7082467

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

10/10/2023

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 9, 10

Data de depósito

29/09/2021

Data de registro

20/06/2023

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

20/06/2023

Última transação

20/06/2023

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

99

Localização do titular

AU

Examinador

CROSS, TRACY L

Unidade examinadora

L90

Localização atual

PUBLICATION AND ISSUE SECTION

Titulares e representantes

Titulares

Diag-Nose Medical Pty Ltd

Representantes

Matthew M. Gardlik, Ph.D. Woodard, Emhardt, Henry, Reeves & Wagner

Classificação técnica

Classes Nice

Classe 5Classe 9Classe 10

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Chemical products for detecting and measuring biomarkers for medical diagnostic purposes; chemical products for detecting and measuring biomarkers for medical diagnostic purposes in the field of rhinology; chemical preparations for detecting and measuring biomarkers for medical diagnostic purposes; biochemical preparations for diagnostic use; diagnostic preparations for medical purposes; diagnostic preparations for medical usesold as a unit

Classe 9

Downloadable application software for analyzing patient data in the field of medical diagnostics; downloadable application software for analyzing patient data in the field of rhinology; recorded computer software for analyzing patient data in the field of medical diagnostics; recorded computer software for analyzing patient data in the field of rhinology; downloadable computer software programs for analyzing patient data in the field of medical diagnostics; downloadable computer software programs for analyzing patient data in the field of rhinology; downloadable software applications for analyzing patient data in the field of medical diagnostics; downloadable software applications for analyzing patient data in the field of rhinology; apparatus for carrying-out diagnostic testsother than for medical purposesscientific purposes

Classe 10

Diagnostic apparatus for detecting and measuring biomarkers for medical purposes; diagnostic apparatus for detecting and measuring biomarkers for rhinologybodily fluids and liquid biopsies; diagnostic instruments for detecting and measuring biomarkers for medical use; diagnostic instruments for detecting and measuring biomarkers for rhinologybodily fluids and liquid biopsies; diagnostic measuring apparatus for detecting and measuring biomarkers for medical use; diagnostic measuring apparatus for detecting and measuring biomarkers for rhinologybodily fluids and liquid biopsies; medical apparatus for diagnostic testing of biological samples; medical diagnostic kits comprised of sample collection apparatus and reagents for detecting and measuring biomarkers; sample collection apparatus and instruments containing chemical reagents for medical diagnostic use; testing apparatus for detecting and measuring biomarkers for medical diagnostic purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

10/10/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

20/09/2023

FIMP

FINAL DISPOSITION PROCESSED

20/09/2023

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

20/09/2023

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

20/06/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

20/06/2023

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/05/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/04/2023

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/04/2023

GPNX

NOTIFICATION PROCESSED BY IB

05/04/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/04/2023

PUBO

PUBLISHED FOR OPPOSITION

04/04/2023

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

15/03/2023

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

15/03/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

15/03/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

23/02/2023

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

31/01/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

31/01/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

31/01/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

31/01/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

31/01/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

31/01/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

31/01/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

31/01/2023

ATRV

ATTORNEY REVIEW COMPLETED

30/11/2022

LIME

LIMITATION FROM THE IB - REQUEST EXAM REVIEW

21/11/2022

RFNT

REFUSAL PROCESSED BY IB

23/08/2022

LIMG

LIMITATION OF GOODS RECEIVED FROM IB

07/08/2022

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/08/2022

RFRR

REFUSAL PROCESSED BY MPU

01/08/2022

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/07/2022

CNRT

NON-FINAL ACTION WRITTEN

11/07/2022

DOCK

ASSIGNED TO EXAMINER

29/06/2022

MAFR

APPLICATION FILING RECEIPT MAILED

19/11/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/11/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/11/2021

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace DIAG-NOSE ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.